Information  X 
Enter a valid email address

Kropz PLC (KRPZ)

  Print   

Wednesday 16 June, 2021

Kropz PLC

Equity Facility Draw Downs

RNS Number : 1435C
Kropz PLC
16 June 2021
 

16 June 2021

Kropz Plc
("Kropz" or the "Company")

Equity Facility Draw Downs

Kropz Plc (AIM: KRPZ), an emerging African phosphate explorer and developer, is pleased to confirm that it has made its quarterly draw down requests under the equity facilities with Kropz's major shareholder, the ARC Fund ("ARC") .   The Company has two equity facilities, with the first being for an amount of US$ 40 million (which cannot exceed ZAR 680 million) as announced on 13 May 2020 ("Original Equity Facility") and the second  for an amount of up to US$ 5 million  (which cannot exceed ZAR 85 million)   ("New Equity Facility"), as announced on 26 February 2021 .  

The fifth draw down under the Original Equity Facility is for US$ 11 million which will be settled by the issue of 140,148,148 new ordinary shares at the issue price of 6.75 pence per share to ARC on 23 June 2021.

In addition, the Company has made the second draw down request of US$ 2 million under the New Equity Facility.  This draw down will be settled by the issue of 34,745,359 new ordinary shares at the issue price of 4.20  pence per share to ARC on 23 June 2021.   

The next draw downs are expected to be made on or about 10 September 2021 and quarterly thereafter, in line with the terms of the Original and New Equity Facilities.

The proceeds drawn down from the Original and New Equity Facilities will be applied to the continuing workstreams on the Elandsfontein and Hinda projects. The Company will provide further updates on project progress in Q3 2021.

 

Admission and Total Voting Rights

 

Application will be made for the 174,893,507 new ordinary shares to admission to trading on the AIM Market of the London Stock Exchange ("AIM"). It is expected that admission will become effective and that dealings in the new ordinary shares will commence at 8.00 a.m. on 23 June 2021 ("Admission").

 

On Admission, the Company's issued share capital will consist of 857,451,609 ordinary shares with voting rights. There are no shares held in treasury.  This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Change in Shareholding

 

Following issue of the  174,893,507 new ordinary shares, ARC Fund will be directly interested in 708,772,716 ordinary shares of the Company representing 82.7 per cent. of the issued share capital.

 

In addition, ARC Fund holds call options over certain shares held by Kropz International S.a.r.l as set out in the announcement on 26 February 2021.

 

Release of annual report

 

The Company is expecting to release its annual results for the year ended 31 December 2020 on 30 June 2021.

 

For further information visit   www.kropz.com  or contact:

 

Kropz Plc


Mark Summers (CEO)

+27 (0)79 744 8708



Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

George Grainger

 

+44 (0) 20 7383 5100



Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

 +44 (0)20 7907 8500


Tavistock

Financial PR & IR (UK)

N ick Elwes

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

[email protected]


R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0)11 880 3924

[email protected] 

About Kropz Plc

Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate mining project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZQLFFFQLFBBL

a d v e r t i s e m e n t